 Linn attenuates complete freund’s adjuvant-induced chronic inflammation in Wistar rats via inflammation response by unknown
RESEARCH ARTICLE Open Access
Melastoma malabathricum Linn attenuates
complete freund’s adjuvant-induced
chronic inflammation in Wistar rats via
inflammation response
Vikas Kumar1*, Prakash Chandra Bhatt2, Kalicharan Sharma2, Mahfoozur Rahman1, Dinesh Kumar Patel1,
Nikunj Sethi3, Atul Kumar4, Nikhil Kumar Sachan3,7, Gaurav Kaithwas5, F. A. Al-abbasi6, Firoz Anwar6*
and Amita Verma1*
Abstract
Background: Natural products use for arthritis treatment is gaining importance in the medical worldt. Various
studies reports medical importance of Melastoma malabathricum Linn. (MM) (Melastomataceae), also known as
“putki,” has a broad range of health benefits, for its free radical scavenging constituents. The current investigation
scrutinizes the antioxidant and anti-inflammatory effect of MM against adjuvant-induced arthritis in experimental rats.
Methods: High-performance thin layer chromatography (HPTLC) was used for estimation of phytochemical-constituents
present in the MM extract. Protective effect of MM extract in Wistar rats was estimated using CFA-induced model. The rats
were divided into different groups with six rats in each group. All animals received oral administration of MM and
indomethacin for 28 days. The body weight and arthritic score were scrutinized at regular intervals. At the end
of experimental protocol, the rats were sacrificed, and blood samples were used for antioxidant, hematological
parameters, pro-inflammatory and inflammatory mediator, respectively. Histopathological observation was used
to evaluate the protective effect of MM extract.
Result & discussion: Current study confirmed the preventive effect of MM against adjuvant-induced paw edema,
paw redness and arthritic progression. MM significantly (P < 0.001) modulated the oxidative stress parameters as
well as hematological parameter induced by CFA. The result also altered the distorted level of proinflammatory
mediators and inflammatory mediator, which further reinforce the implication of MM in CFA induced arthritis.
Histological analyses of joints of rats showed a reduction in the synovial hyperplasia and mononuclear infiltration
in the MM treated group which provides evidence for the antiarthritic effect of MM.
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Conclusion: From above parameters our study states that the MM is capable of restraining the alteration produced via
adjuvant-induced arthritis in aminals. The repressing effect of MM could be attributed, at least in part, to antioxidant,
hematological and anti-inflammatory effect.
Keywords: Melastoma malabathricum Linn, Complete Freund’s Adjuvant, Pro-inflammatory mediator, Inflammatory
mediator
Background
Rheumatoid arthritis (RA) is a chronic immune-mediated
inflammatory disease, which finally results in damage of
ligaments, peripheral joints and tendons. RA affects around
1% people in developed countries [1–5]. RA is further de-
fined as the inflammatory condition of joints, which pro-
duces the pain, immobility and inflamed condition with
excess deposition of synovial fluid (accumulation of poly-
morphonuclear leukocytes) [6, 7].. NSAIDs (Nonsteroidal
anti-inflammatory drugs) are well established class of drugs
used by many physicians on their patients as a first line
antiarthritic drug, but they have side effects such as gastric
erosion, ulceration, liver toxicity, inhibition of platelet
activation and gastrointestinal hemorrhage, which conse-
quently result in increased risk of hemorrhage [8, 9]. A lot
of drugs have been developed for the treatment of RA over
the past two decades, but researchers are still in search for
more specific drugs with minimum side effects. Researchers
were able to explain the one of the herbal formulation
piascledine, which is the mixture of avocado and soybean
oils sfor relief of inflammatory arthritis symptoms. Several
other small anti-inflammatory compounds isolated from
natural sources have been scrutinized for the development
of new lead molecule in the treatments for RA, but scien-
tific data of their antiarthritic efficacy is still deficient and
need more thorough study.
Melastoma malabathricum Linn. (Melastomataceae)
(MM), commonly known as Phutki in India, is a
branched shrub available in subcontinent, especially in
northeastern region. Traditionally, its leaves are chewed
and applied to cuts and wounds for their coagulating
properties. The leaves are used to treat hemorrhoid, dys-
entery, diarrhea and to prevent scarring from the pox.
The shoots are used as a toothbrush for toothache,.
Leaves and roots powder can be applied to pox scars
and wounds to expedite the healing process or to allevi-
ate the uneasiness of hemorrhoids. Flowers are used to
treat stomach-ache [10, 11, 12]. MM plant has been uti-
lized in the treatment of inflammation and rheumatism
by the local people in Dibrugarh district, Assam. The
plant is rich source of different chemical constituents
such as α-amyrin, patriscabatine and auranamide [13],
kaempferol-3-O-(2”,6”-di-O-p-trans-coumaroyl)glucoside,




Researchers have proved the antinociceptive, anti-
inflammatory, antipyretic [15, 16], antidiarrhoeal [17],
antimicrobial [18], antiproliferative and antioxidant [19],
antiulcer activity [20], acute toxicity evaluation, antibac-
terial, antioxidant and immunomodulatory effects and
hepatoprotective activity [21, 22] of the plant. However,
this plant is not scientifically explored for its antiarthritic
activity. Hence, efforts were made by the authors to
screen the antiarthritic potential of MM.
Methods
Drugs and chemicals
CFA was procured from Sigma Chemical Company, USA
and Indomethacin from Micro Lab Pvt. Ltd., India. Rest of
the chemicals used in the experimental protocol was pur-
chased as an analytical grade from the approved vendor.
Plant material
MM leaves were collected from the Herbal Garden,
Dibrugarh University, Dibrugarh, Assam and authenticated
by the Botanical Survey of India, Shillong and specimen
voucher of plant sample was deposited for future reference.
Preparation of extracts
MM leaves were thoroughly cleaned with tap water to
eliminate extemporaneous matter and dried in the shade.
The dried MM (1 kg) leaves samples were exhaustively
extracted with methanol in Soxhlet extractor for 72 h [23,
24]. The extract was filtered using the Whatman filter
paper and the filtrate was concentrated under reduced
pressure at low temperature. The extract was stored
at 4 °C until further use. Before experimentation, MM
extract was freshly prepared by dissolved in 1% carboxyl
methyl cellulose (CMC) for experimental study.
Chromatography experiment
Pre-coated silica gel plate 60 F254 with a width (6 mm
band) used for the HPTLC. Camag microliter syringe
with a Linomat 5 applicator was used for injecting the
sample over the plate under a flow of Nitrogen gas. The
mobile phase {Hexane/ethyl acetate/formic acid (5:4:1,
v/v/v)} was used in linear ascending development. The
saturation time for mobile phase was about 20 min in
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saturation chamber to obtain the best results of tested
and reference samples at room temperature (27 ± 20 °C)
with 50% ± 2 relative humidity. Finally, the TLC (Thin
layer chromatography) plate was dried at room tem-
perature and the TLC plate image was developed at the
distance of up to 80 mm length.
HPTLC (High-Performance Thin Layer Chromatography)
photo-densitometry
HPTLC study of MM extract was carried out according to
reported method of Kumar et al. with minor modification
[25]. Quercetin (10 mg) was dissolved in 10 mL of metha-
nol for preparing the standard solution and MM (2.0 g)
extract solution was dissolved in 50 mL of methanol and
was subjected to filtration using the Whatman filter paper.
The filtrate was completely evaporated under reduced pres-
sure and the obtained remains were re-dissolved in 1 mL of
methanol. The prepared solution of quercetin and MM
extract was carefully spotted on the precoated TLC plates
using Camag microliter syringe with constant application
150 nL/s.
Molecular docking studies
The molecular docking study was performed on cyclooxy-
genase 2 (3D structure) complex enzyme using Maestro 9.0
program (Schrodinger Inc. USA) by 64 bits operating sys-
tems under Windows 7 with an HCl computer [Intel (R)
Core (TM) i5-2400 CPU @ 3.10 GHz, 8GB memory]. The
molecular docking study was performed on enzymes cyclo-
oxygenase, which was taken from the protein data bank
(PDB ID: 1cx2). The protein is having the 96% similarity
with the human cell enzyme with all the active site residues.
Before performing the molecular docking, the enzyme
structure was scrutinized for missing bonds, atoms and
contacts. All residues and water molecules were manually
removed from the structure. The grid box was used for the
estimation of the active site of the protein. The minimum
energy was selected and used an energy minimization.
Animals
Swiss albino adult Wistar rats (weighing 150–220 g; both
sexes, kept six per cage) were obtained from the departmen-
tal animal house and were used according to departmental
ethical committee and care of animals (National Institutes
of Health). The animals were housed in the animal house
under standard conditions (relative humidity (55 ± 10%),
temperature (23 ± 1 °C), 12 h/12 h light/dark cycles) they re-
ceived the standard pellet diet and water ad libitum.
Acute toxicity study of MM
Oral acute toxicity study of MM extract was performed
according to the reported method of Kumar et al. with
minor modifications [25]. Swiss albino Wistar rats of
both sexes (weighing 100 to 220 g, body weight) were
used for the experimental purpose. The rats were rav-
enous overnight and divided into the four groups (each
group of rats contained three male and three female
rats): Group I: (normal control) treated with vehicle
only (1 mL water) and Group II (tested) received MM
(0.5 g/kg); Group III received MM (1.0 g/kg, body
weight (b.w.)) and Group IV received MM (2.0 g/kg
b.w.), respectively. All group animals were examined
for 24 h, for the confirmation of signs and symptoms of
autonomic, neurological and behavioral changes [26].
Sub acute toxicity study of MM
Swiss albino Wistar rats (weighing 100 to 220 g; both male
and female) were randomly selected randomly for the study.
The animals were divided into four groups and each group
contains animals (five male and five female): Group I- nor-
mal controls received vehicle (1 mL water); Group II-
treated MM (500 mg/kg b.w.); Group III- treated MM
(1000 mg/kg b.w.); Group IV- treated MM (2000 mg/kg
b.w.). All animals treated with predetermined oral treatment
and MM extract which was suspended in distilled water.
All group animals were observed for adverse reactions,
side effects, mortality and any other changes at end of the
sub acute toxicity study. The food consumption, water in-
take and body weight of all group animals were scrutinized
at regular intervals. At the end of protocol nimals were
sacrificed by cervical dislocation using the anesthesia condi-
tion, all the vital organs of animals were scrutinized visibly
for evidence of any morphological deformity and blood
samples of all group animals were collected and were used
for the estimation of serum biochemistry like RBC (red
blood cells), WBC (white blood cells), Hb (hemoglobin) and
platelets levels and the biochemical parameters like AST
(Aspartate aminotransferase), ALP (Alkaline phosphatase),
ALT (Alanine transaminase), total cholesterol, LDL (Low-
density lipoprotein), VLDL (Very low-density lipoprotein),
HDL (High-density lipoprotein), triglyceride, bilirubin, albu-
min, creatinine, total protein and serum urea were also
estimated [53]. The vital organs such as kidney, heart and
liver were excised, removed and weighed. Samples of extra-
neous tissues were removed, fixed in 10% formalin and
dehydrated for histopathological examinations [27].
Oral administration of drugs
The flexible metal rodent feeding tube was used for oral ad-
ministration of tested and reference drugs. Mis-feeding of
tested and reference drugs into trachea was perceived by
signs of an irregular breathing pattern, irritation and choking.
When the misfeeding transpired (less than 5% of all feed-
ings), the rats were carefully observed for their revival [28].
Complete Freund’s Adjuvant-induced arthritis in rats
The rats were divided into six groups (each group 6
rats). Group I was treated with vehicle (1% (w/v) CMC);
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II received CFA; III received CFA +MM (100 mg/kg); IV
received CFA +MM (250 mg/kg); V received CFA +MM
(500 mg/kg) and Group VI received CFA + indomethacin
(10 mg/kg). CFA (0.5% w/v) was inducted into the sup-
planter region of left hind paws to induced the arthritis.
All the animals received the predetermined treatment till
28 days [29, 30] with paw edema of rats subjected to
scrutinized at a regular interval using the screw gauge
micrometer [31].
Evaluation of arthritis swelling
The joint swelling (arthritis index) was evaluated by
the reported method of Kumar et al. [25] with minor
modifications. The arthritic index was assessed on scale
0–4, 0: no change, 1: mild swelling and erythema of
limb, 2: erythema of limb and moderate swelling, 3:
erythema of limb and coarse swelling, 4: the inability of
limb and gross deformity. The score of the four limbs
was counted. Score more than one, confirmed arthritis
and limited score of arthritis was set to 16. The arth-
ritis score day of onset and frequency of arthritis was
also recorded [32].
Blood and tissue sampling
Rats of all groups were sacrificed on 29th day, and blood
samples were collected in test tubes with anticoagulation
agent. The collected blood samples were centrifuged
at 15,000 rpm, and the serums were obtained for the
estimation of biochemical parameters.
Estimation of proinflammatory and inflammatory mediators
The proinflammatory mediators such as interlukin-1β
(IL-1β), interlukin-6 (IL-6) and tumor necrosis factor-α
(TNF- α) inflammatory mediators such as cyclooxygenase
2 (COX- 2) were estimated using the manufacturer in-
structions of Enzyme Linked Immunosorbent Assay kits.
Histopathology examination
The left paw of all groups rats were cut above and below
the 0.5 cm of joints. The muscle and skin of joints were
trimmed away to leave the intact synovial membrane.
All tissues were processed with the 3% hydrochloric acid
(HCl) solution for 5–7 days, with periodic change of
HCL on every 24 h for complete decalcification of joints.
After that, the joints were fixed in the neutral buffered
formalin (10%) for 2 days. Decalcified joints of rats were
again dehydrated in different series of alcohol and joints
were cleared and embedded in liquid paraffin. Decalcified
joints were sliced g into 5 μm pieces with hematoxylin
and eosin used for staining the tissue and preparing the
slide. The slides were prepared for microscopic evaluation
under light microscope (original magnification 40×, DXIT
1200, Nikon, Japan). H&E stained joint slides were
examined for bone and cartilage destruction by synovial
proliferation, cellular infiltration, and cartilage erosion by
the following scoring system.
a. Synovial proliferation
For the estimation of synovial proliferation, the
following score system was used. No change = Score
0; mild proliferation with 2–4 layers of synoviocytes =
Score 1; moderate proliferation with four or more
layers of synoviocytes, absent synovial cell invasion of
adjacent connective tissue and bone with enhanced
mitotic activity = Score 2; provide proliferation
distinguished by adjacent cartilage and effacement of
joint space, connective tissue and bone.
b. Cellular infiltration
Cellular infiltration: no changes: Grade 0; the small
number of focal infiltrates: Score 1; extensive focal
infiltration: Score 2; widespread infiltrates assaulting
the capsules with combined formation: Score 3.
c. Cartilage erosion
No changes: Score 0; localized cartilage ruin in more
than one region: Score 1; cartilage ruin: Score 2;
thick cartilage ruin different locations.
Statistical analysis
All the results were presented as mean ± SEM (standard
error mean) using the one-way ANOVA {Graph Pad Prism
5.0 (Graph Pad Software, San Diego, CA, USA)}. The values
of the result were considered to be significant, when the P
value was p < 0.05, p < 0.01 and p < 0.001.
Results
HPTLC analysis
Various composition and amalgamations of the mobile
phase were used for the required resolution of phytocon-
stituent (quercetin). Mobile phase solvent combination
{Hexane, Ethyl acetate and formic acid (5:4:1, v/v/v)}
gave a compact and dense spot. The presence of quer-
cetin in the MM was confirmed by comparison of Rf
value of standard quercetin. The sample bands at Rf 0.62
corresponded to quercetin (Figs. 1 and 2).
Molecular docking study
We have performed the molecular modeling docking stud-
ies via automated docking method into the ATP-binding
site of COX-2 with s58 at 3.0 A° resolution complex (PDB
code: 1cx2). The binding pose found by Maestro 9.4 for
quercetin against COX-2, presented in Fig. 3. It can be ob-
served from e molecular docking studies, that these mole-
cules are located in such a way that the quercetin hydroxyl
group creates hydrogen bond with the backbone of OH
residue (Ser 530) and NH of His 90 in the hinge section.
For further refinement of results, we superimposed the
quercetin with s58 analyses and found the orientation of
quercetin same as s58 in the COX-2 catalytic domain.
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Fig. 1 High performance thin layer liquid chromatography (HPTLC) profiles of Melastoma malabathricum Linn. methanolic extract
Fig. 2 High performance thin layer liquid chromatography (HPTLC) profiles of Quercetin
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For better understanding, the binding mode of quer-
cetin at the molecular level, the molecular docking
simulations of quercetin at the COX-2 catalytic ligand-
binding site was carried. The Schrodinger software
suite was used for the estimation of simulation. The
ligand was prepared in the 3D format using the ligprep.
The protein was obtained from the protein data bank
(PDB ID: 1cx2), and made ready by removing the
solvent, adding hydrogen and further minimization the
bound ligand (s58) (Fig. 4). The re-docking study was
carried for validation of co-crystal ligand parameters
(s58) at the protein catalytic site, and re-docked pose
was found to be 0.249 A (Fig. 5).
Oral toxicity study
Oral administration of MM (500 to 2500 mg/kg b.w.)
did not produce any change in the clinical or behavioral
signs and symptoms, mortality or any other types of
Fig. 3 Binding interaction of quercetin with cox2 catalytic domain (pdbid-1cx2)
Fig. 4 Ligplot of quercetin with cox2 enzyme
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adverse reactions at the end of study. The experimental
animals did not show any change in food consumption
and body weight during the study period. Similar results
were obtain during e subacute toxicity study, when com-
pared to normal rats, confirm the safety of MM even upon
continuous oral administration for 28 days, irrespective of
the sex of rats. The results of subacute study on relative
body weight of kidney (0.78 ± 0.02 g), liver (3.73 ± 0.42 g)
and heart (1.98 ± 0.07 g) in male Wistar rats; and the rela-
tive body weight of kidney (0.54 ± 0.02 g), liver (2.45 ±
0.31 g) and heart (1.34 ± 0.17 g) in female Wistar rats.
The relative organ weight of all MM (2500, 1250 and
625 mg/kg, b.w.) treated groups was almost similar to
normal rats. These results indicate the body weight of
normal male rats was enhanced from 140.3 ± 3.43 to
189.5 ± 8.34 with gain growth rate of 1.76 ± 0.23 and
the body weight of female Wistar rats has been im-
proved from 123.4 ± 2.83 to 156.2 ± 6.43 with 1.17 ±
0.19 growth gain rate. The body weight of MM
(2500 mg/kg b.w.) was enhanced from 142.5 ± 6.43 to
201.2 ± 11.34 with growth gain rate 2.09 ± 0.53 and fe-
male rats treated with MM (2500 mg/kg b.w.) in-
creased body weight 125.3 ± 4.32 to 161.3 ± 8.49 with
1.29 ± 0.31 growth gain rate and MM (1250 mg/kg
b.w.) enhanced body weight from 145.8 ± 4.93 to
198.3 ± 9.76 with growth gain rate 2.1 ± 0.16 in male
Wistar rats and in female Wistar rats improved the
body weight 126.4 ± 3.21 to 151.2 ± 8.32 with growth
gain rate 0.88 ± 0.04 per day, respectively. MM
(625 mg/kg b.w.) enhanced the body weight 147.4 ±
2.45 to 176.3 ± 6.34 in male Wistar rats with 1.03 ±
0.03 growth gain rate and 124.6 ± 1.98 to 145.3 ± 8.23
in female Wistar rats with 0.73 ± 0.08 growth gain
rate per day, respectively (Table 1).
The acute toxicity study did not show any significant
transformation in hematological and biochemical param-
eters of MM treated rats. MM treated rats confirmed the
proper range of hepatic and renal parameters as com-
pared to normal rats. There was no significant alteration
in lipid profile such as triglycerides, cholesterol, LDL,
HDL and VLDL as compared to normal control by MM
(Table 1).
The histology of normal and MM treated rats did
not show any change in the appearance of the rat
organs (Fig. 6).
Effect of MM on adjuvant-induced arthritis
The rats developed the swelling and redness over 24 h
after the adjuvant treatment and reached extreme inten-
sity on day 4 (first stage of swelling developed). Conse-
quently, redness and swelling slowly augmented until the
8th day and subsequently, rats re-developed the redness
and swelling. Arthritis developed during the secondary
swelling, with more predominant swelling and redness, as
a comparison to first stage. The secondary stage swelling
was maximum by 25th day of study. Pre-treatment of MM
significantly (P < 0.001) censored the swelling and re-
pressed the paw edema/redness in dose dependent man-
ner (Fig. 7a). MM (500 mg/kg) showed the better recovery
of the rats as compared to indomethacin treated group.
Clinical assessment of rat ankles signified that the AC rats
confirmed the maximum arthritis score which was consid-
erably higher than the normal rats. AC rats treated with
MM significantly (P < 0.001) produced a dose dependently
inhibition of arthritic score as compared to AC rats
(Fig. 7b). Considering the arthritic score, MM (500 mg/kg)
and indomethacin significantly (P < 0.001) showed the bet-
ter protection of rats during the arthritis, but the
Fig. 5 Superimposition of quercetin with s58 with cox2 catalytic domain
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treatment by MM (500 mg/kg) was superior in compari-
son to indomethacin.
The cartilage erosion, synovial proliferation, and cell in-
filtration assessment between the different groups resulted
in AC rats confirmed the higher score as compared to
normal rats. Pre-treatment with MM, considerably re-
strained the histologic score as compared to AC group
rats. Prominently, MM (500 mg/kg b.w.) inhibited the
histologic score compared to Indomethacin group. Both
MM (500 mg/kg) and indomethacin showed the protec-
tion/superiority over the arthritis disease but MM
(500 mg/kg) demonstrated more superiority as compared
to indomethacin group, which was confirmed by the
histological observation. MM illustrated the average score
0.67 and indomethacin showed the average score 0.84
(Table 2).
Body weight declined in AC rats at the end of experi-
mental study (Fig. 8). AC rats treated with MM and Indo
significantly (P < 0.001) improved the body weight in
dose dependent manner. (Fig. 8).
Effect of MM on hematological parameters
CFA made a compelling upsurge in fructification of WBC
(8 ± 0.32 cells/cu.mm). The MM treatment conferred im-
portant protection from the same, just about consistently
(Fig. 6). Similarly, outstanding enhancement of ESR was
noted in AC control (14 ± 0.46 million/cu.mm (gm%) in
counterpart to normal control (9.8 ± 0.29 million/cu.mm
(gm%). Concomitant administration of MM significantly
(P < 0.001) altered the WBC and ESR. Compelling subsid-
ence in the hematological parameters of RBC as perceived
in AC (4.4 ± 0.25 million/cu.mm). Similarly, the outstand-
ing decline in Hb was noted in AC (9.6 ± 1.37 cells/
cu.mm) in counterpart to normal control AC (13.6 ± 0.54
cells/cu.mm), it is notable that treatment with MM helped
to restore the hematological parameters of RBC and WBC
synchronously (Fig. 9).
Effect of MM on antioxidant enzymes
We also examined the antioxidant parameters (Fig. 10).
As expected, CFA treatment considerably increased the
Table 1 Effect of administration of Melastoma malabathricum Linn. (MM) (28 days) on biochemical and hematological parameters
in Wistar rats (Male and Female)
S.
No
Parameters Normal control MM (500 mg/kg, b.w.) MM (1000 mg/kg, b.w.) MM (2000 mg/kg, b.w.)
Male Female Male Female Male Female Male Female
General effect
1 Body Weight (gm) 189.5 ± 8.34 156.2 ± 6.43 176.3 ± 6.34 145.3 ± 8.23 198.3 ± 9.76 151.2 ± 8.32 201.2 ± 11.34 161.3 ± 8.49
2 Water Intake (mL) 102 63 83 65 94 71 104 84
3 Food Intake (gm) 52 44 32 22 44 32 54 46
Hematology
1 RBC (106/cu mm) 6.43 ± 1.21 5.11 ± 1.02 5.98 ± 1.04 5.08 ± 0.95 6.87 ± 1.65 5.21 ± 1.43 7.65 ± 1.76 5.98 ± 1.09
2 WBC (103/cu mm3) 8.99 ± 1.43 7.21 ± 1.84 11.2 ± 1.65 9.43 ± 1.54 10.33 ± 1.64 8.65 ± 1.65 9.01 ± 1.59 7.43 ± 1.94
3 Hb (g dL−1) 13.01 ± 2.03 12.02 ± 2.21 12.54 ± 11.45 11.73 ± 1.98 13.06 ± 2.53 12.32 ± 2.04 14.03 ± 2.83 12.98 ± 2.47
4 Platelet (105/cu mm) 4.01 ± 0.73 3.83 ± 0.49 6 ± 2.01 5.87 ± 1.84 5.21 ± 1.03 5.01 ± 1.13 4.06 ± 0.94 3.78 ± 0.73
5 Eosinophils (mm3) 796 ± 293 498 ± 165 598 ± 384 398 ± 194 654 ± 403 432 ± 214 731 ± 421 489 ± 283
6 Lymphocyte (mm3) 3990 ± 850 2983 ± 594 4350 ± 1039 3214 ± 843 4256 ± 989 3103 ± 784 4013 ± 985 3023 ± 775
7 Neutrophils (mm3) 1596 ± 748 1374 ± 398 1698 ± 983 1485 ± 748 1602 ± 894 1398 ± 738 1545 ± 938 1367 ± 738
Biochemical
1 ALP (UL−1) 221 ± 21.83 209 ± 19.3 298 ± 31.78 285.2 ± 27.31 276.23 ± 24.54 244.5 ± 21.6 234 ± 24.5 213 ± 21.3
2 ALT (UL−1) 61.3 ± 2.34 50.32 ± 2.56 ± ± ± ± ± ±
3 AST (UL−1) 103.2 ± 7.65 80.1 ± 7.87 90.3 ± 6.65 71.3 ± 8.76 95.6 ± 8.65 76.4 ± 7.54 102.3 ± 5.65 79.5 ± 6.87
4 Bilirubin (mg dL−1) 0.52 ± 0.09 0.36 ± 0.07 0.68 ± 0.08 0.43 ± 0.06 0.62 ± 0.06 0.41 ± 0.07 0.55 ± 0.08 0.40 ± 0.05
5 Creatinine (mg dL−1) 0.71 ± 0.43 0.52 ± 0.11 0.86 ± 0.22 0.64 ± 0.15 0.79 ± 0.14 0.58 ± 0.17 0.72 ± 0.21 0.54 ± 0.14
6 Urea (mg dL−1) 36 ± 3.21 26 ± 2.65 41.3 ± 4.54 35.1 ± 3.43 39.3 ± 3.54 32.1 ± 2.45 36.2 ± 4.32 28.5 ± 3.34
7 Cholesterol (mg dL−1) 71.3 ± 1.76 72.5 ± 1.54 82.6 ± 2.33 85.6 ± 3.46 79.6 ± 2.45 83.5 ± 3.43 75.3 ± 4.32 78.4 ± 3.45
8 Triglyceride (mg dL−1) 74.5 ± 1.87 86.7 ± 1.65 88.3 ± 1.76 89.6 ± 1.45 92.2 ± 2.43 93.3 ± 3.21 90.32 ± 2.32 92.3 ± 3.24
9 HDL (mg dL−1) 26.4 ± 1.41 20.6 ± 1.23 28.7 ± 2.73 22.4 ± 1.54 26.1 ± 1.83 21.3 ± 2.65 25.3 ± 2.43 20.3 ± 1.93
10 LDL (mg dL−1) 37.1 ± 1.23 49.83 ± 1.65 51.79 ± 2.13 60.73 ± 1.94 53.69 ± 1.86 61.91 ± 2.01 49.81 ± 1.28 58.01 ± 1.98
11 VLDL (mg dL−1) 14.9 ± 1.34 17.34 ± 1.67 17.66 ± 1.98 17.92 ± 1.56 18.44 ± 1.45 18.66 ± 1.76 18.06 ± 1.34 18.46 ± 1.54
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MDA enzyme activity and decreased the activities of
SOD, GSH and GPx. AC rats treated with MM signifi-
cantly (P < 0.001) altered the antioxidant enzymes to
near the normal rats in dose dependent manner.
Effect of MM on inflammatory mediators
The levels of COX-2, IL-6, TNF-α and IL-1β were
augmented in the serum after CFA treatment. AC rats
received oral administration of MM apparent supple-
mentary increase of the same (Fig. 11).
Effect of MM on histopathology of CFA-induced rats
The histopathology observation of normal control and
CFA-induced rats are showed in Fig. 12. The normal rat
histopathology explained clean articular surface among
1–4 layers of synovial cells and normal articular smooth
surface with a loose connective tissue. This also con-
tained the fatty tissue below the synovial membrane. AC
control rat histopathology showed the hyperplasia in the
articular region with the loose connectivity of tissue.
The synovial defect showed the distortion of pannus for-
mation of bone and cartilage. The deformity of the joint
was widespread resulted due to increased sizes and con-
nectivity of synovial membrane. AC showed the loose ar-
rangement of connectivity of tissue due to hyperemia,
edema and infiltration with provocative cells (Fig. 12b).
AC rats treated with MM showed the remarkable restor-
ation of all histology characteristics in dose dependent
manner. MM dose (500 mg/kg b.w.) displayed enhanced
histopathology as compared to MM dose (100 and
250 mg/kg b.w.) (Fig. 12 c-e).
Discussion
Arthritis is a chronic painful inflammatory disease, af-
fecting more than 1% population in developed countries.
On the basis of biochemical markers, CFA-induced
Fig. 6 Histopathological examination of different vital organ of normal control and Melastoma malabathricum Linn. (MM) treated rats in sub acute
toxicity study. Heart (NC): blue arrow shows the normal intercalated disc. Heart (MM): Black arrow depicts the normal intercalated disc. Kidney (NC):
Yellow arrow demonstrates the normal tubules and glomerulus. Kidney (MM): Green arrow indicates the normal tubules and glomerulus. Liver (NC):
Brown arrow showed the normal structure of portal and central vein of the normal hepatocytes. Liver (MM): Green arrow confirms the average size
of portal and central vein of normal hepatocytes
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Table 2 Effect of administration of Melastoma malabathricum Linn. (MM) on the scores of histopathological changes in CFA induced
arthritic group rats
S. No Histological changes Groups
AC AC +MM (100 mg/kg) AC +MM (250 mg/kg) AC +MM (500 mg/kg) AC + Indo (10 mg/kg)
1 Synovial proliferation
Grade 0 - - - 2 1
Grade 1 - - - - 1
Grade 2 - 2 2 2 2
Grade 3 5 2 1 - -
Total 15 10 7 4 5
mean 3 2.5 2.3 1 1.25
2 Cartilage erosion
Grade 0 - - 2 4 3
Grade 1 - 2 2 1 1
Grade 2 2 1 - - -
Grade 3 3 - - - -
Total 13 4 2 1 1
mean 2.6 1.33 0.50 0.20 0.25
3 Cellular infiltration
Grade 0 - - - 3 3
Grade 1 - 1 2 2 1
Grade 2 - 2 2 1 2
Grade 3 5 1 - - -
Total 15 10 6 4 5
mean 3 2.5 1.5 0.67 0.84
Fig. 7 Effect of Melastoma malabathricum Linn. (MM) on CFA induced arthritic rats. Arthritic was assessed in terms of enhanced of (a) Paw edema
and (b) Arthritic index as described in Materials and methods. ns = non-significant, CFA = Complete Freund Adjuvant, NC = Normal Control,
AC = Arthritic Control. The comparisons were made by ANOVA followed by Dunnett’s test. *P < 0.05 is considered as significant, **P < 0.01 is
considered as very significant, ***P < 0.001 is considered as extremely significant
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arthritis is clinically classified into four phases, initial
phase developed during the first week after injecting the
CFA with acute local inflammation and having some ef-
fects on liver; in the second week afterward, extend the
reduction of acute inflammation and start the periarteri-
tis; third-fourth week develops the arthritis with chronic
inflammation, osteogenic and periarteritis activity, there-
fore, the fifth week onwards (forever), with permanent
articular deformity and minimal inflammation [33, 34].
Our study showed the credible protecting impact of
this plant against the chronic inflammation induced by
CFA. The results confirmed the use of MM extract as an
antiarthritic agent in Indian folk medicine on the scien-
tific basis. The conclusion of this study clearly explains
that the MM extract is a potent antiarthritic remedy
against chronic phases of inflammation. Topical and
systemic application of MM is commonly observed for
the treatment of inflammation, predominantly, arthritis
(ama vata) which has been pursued for many years in
the practice of Indian system of medicine (Ayurveda).
MM extract is a rich source of the flavonoids (quer-
cetin). Flavonoids play an important role to inhibit the in-
flammation via apoptotic mechanism (calcium dependent)
or cyclin-dependent kinase inhibitors; modify the cell cycle
capture at the G1/S phase (Extracellular growth signals
stimulate progression through the first gap phase G1, and
into S, where genomic DNA is replicated); inhibit the cell-
survival kinase and the inflammatory transcription factors;
down-regulate the antiapoptotic gene products [34, 35].
The CFA-induced arthritis model is the most extensively
use model to investigate the clinical and pathogenic
changes, which are similar to human arthritis [25]. Further
this method helps in determining the correlation between
efficacy of therapeutic agents and RA model [36, 37]. The
adjuvant-induced inflammatory process involves fenes-
tration of microvasculature, leakage of element into the
interstitial space and passage of macrophages, lympho-
cytes into inflamed tissue; where adjuvant inoculation
releases the number of inflammatory mediators like cy-
tokines, histamine, 5 hydroxytryptamine, bradykinin,
Fig. 9 Effect of Melastoma malabathricum Linn. (MM) on CFA induced arthritic rats. Arthritic was assessed in terms of modulation of (a) WBC,
(b) RBC, (c) Hb and (d) ESR as described in Materials and methods. ns = non-significant, CFA = Complete Freund Adjuvant, NC = Normal Control,
AC = Arthritic Control, WBC =White blood cell, RBC = Red blood cell, Hb = Hemoglobin, ESR = Erythrocyte sedimentation rate. The comparisons
were made by ANOVA followed by Dunnett’s test. *P < 0.05 is considered as significant, **P < 0.01 is considered as very significant, ***P < 0.001 is
considered as extremely significant
Fig. 8 Effect of Melastoma malabathricum Linn. (MM) on CFA
induced arthritic rats. Arthritic was assessed in terms of alteration
of body weight as described in Materials and methods. ns = non-
significant, CFA = Complete Freund Adjuvant, NC = Normal Control,
AC = Arthritic Control. The comparisons were made by ANOVA
followed by Dunnett’s test. *P < 0.05 is considered as significant,
**P < 0.01 is considered as very significant, ***P < 0.001 is considered
as extremely significant
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various chemotactic factor, interferons and prostaglan-
din into inflamed area. These mediators are liable for
demolition and destruction of bone, cartilage and associ-
ated with pain, which can lead to several disabilities.
Other mechanisms involves leukocytes and phagocytes,
preparing a complex with the mediators, releasing the
lysosomal enzymes and causing the injury of cartilage
and other tissue. CFA affected the soft tissue and created
the swelling near the ankle joints confirm the expansion
of arthritis which was measured as edema of the particu-
lar tissues [38, 39]. In the current study, the efficacy of
MM treated rats was evaluated in the proliferative phase
of inflammation, showing the minimization of the
chronic swelling induced by CFA. The first indication of
the antiarthritic effect of MM was observed when the
administered extract (100, 250 and 500 mg/kg) showed a
significant dose-dependent reduction of paw edema with
59.17%, 74.16%, and 87.72%, as compared to AC rats
Fig. 11 Effect of Melastoma malabathricum Linn. (MM) on CFA induced arthritic rats. Arthritic was assessed in terms of modulation of proinflammatory
mediators such as (a) TNF-α, (b) IL-6, (c) IL-1β and (d) COX-2 as described in Materials and methods. ns = non-significant, CFA = Complete Freund
Adjuvant, NC = Normal Control, AC = Arthritic Control, TNF-α = Tumor necrosis factor-α, IL-6 = Interlukin-6, IL-1β = Interlukin 1β. The comparisons
were made by ANOVA followed by Dunnett’s test. *P < 0.05 is considered as significant, **P < 0.01 is considered as very significant, ***P < 0.001 is
considered as extremely significant
Fig. 10 Effect of Melastoma malabathricum Linn. (MM) on CFA induced arthritic rats. Arthritic was assessed in terms of modulation of (a) MDA,
(b) GPx, (c) SOD and (d) GSH as described in Materials and methods. ns = non-significant, CFA = Complete Freund Adjuvant, NC = Normal Control,
AC = Arthritic Control, MDA =Malonaldehyde, GPx = Glutathione peroxidase, SOD = Superoxide dismutase, GSH = Glutathione. The comparisons
were made by ANOVA followed by Dunnett’s test. *P < 0.05 is considered as significant, **P < 0.01 is considered as very significant, ***P < 0.001 is
considered as extremely significant
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respectively. However, MM received rats did not show
enhancement of joint diameter, which suggests that
mechanisms involved, is inhibition of inflammatory au-
tacoids. The most likely mechanism for MM extract may
be inhibition of proinflammatory mediators, which could
have lead to an alteration in the immunological situation
during the delayed phase of the response. The determin-
ation of body weight and foot thickness of CFA-induced
arthritis animals has been used to evaluate the antiar-
thritic effect of drug treatment. We found increased
body weight of rats with decreased thickness of rat paw
as compared to AC rats.
AC rats confirmed the decline level of RBC, Hb and
increased levels of WBC, ESR. WBC is an important
component of an immune system which is associated
with induction of inflammation and is related to other
infectious diseases [40]. During the arthritic condition,
1 L-1β mediated increase in WBCs, cause the growth of
colony stimulating factors and production of inflamma-
tory macrophages and granulocyte [41]. MM treated rats
significantly suppressed the migration of inflammatory
macrophages and granulocytes in dose dependent man-
ner. On the other hand, increased ESR levels start the
generation of endogenous proteins (fibrinogen, α/β
globulin) and indicate the disease progression [42]. Dur-
ing the arthritic condition, decreased levels of RBC and
Hb, associated with anemic condition due to erythrocyte
deformability (shorten the life span of erythrocytes),
which result in declined level of RBC during arthritis
[43, 44]. It is projected that the declined levels of Hb
during arthritis, results in reduction of erythropoietin
level (decreased the level of bone marrow erythropoietin
level) and premature destruction of RBCs [28, 45]. Res-
toration of hematological parameters to normal by MM
extracts supports its anti-arthritic effect.
ROS/RNS/free radical incessantly formed inside the
body as a consequence of exposure to many endogenous
and exogenous chemicals. There is equilibrium between
the antioxidants and generated ROS/RNS, as the gener-
ation of ROS/RNS is stabled by endogenous antioxidants.
Any disparity among the inactivation and production of
ROS/RNS species leads to cellular dysfunction and un-
wanted pathological conditions including RA [46]. The
ROS/RNS species start the deprivation of synovial fluid
and induce the depolymerization of hyaluronic acid which
turns the loss of viscosity in joints [47]. The human body
has an efficient mechanism to avoid and deactivate the
free radical generation/production damage caused by en-
dogenous antioxidants such as SOD, GSH, GPx and CAT.
SOD is metalloprotein that is the first line antioxidant
marker involve in antioxidant defense. Decreased levels of
RBCs in arthritic conditions increase the production of
superoxide (O2) and hydrogen peroxide radicals (H2O2)
due to accumulation of inflammatory macrophages and
granulocytes in the inflamed area [47, 48]. Lipid peroxida-
tion (LPO) is a common feature of rheumatic arthritis.
MDA (as an indicator of lipid peroxidation) is used to
evaluate the LPO. MDA is a pro-oxidant factor which de-
termines the oxidative stress present in the rats [48]. AC
rats showed increased levels of MDA as compared to NC
Fig. 12 Histopathological effect of Melastoma malabathricum Linn. (MM) on CFA induced arthritic rats. a Normal Control: showed the normal
architecture of articular cartilage; b AC control: showed the bone erosion, mononuclear cell infiltration and deformity of the bone with the
presence of leukocytes infiltration (red arrow) and synovitis (blue arrow); c AC control +MM (100 mg/kg b.w.) showed the leukocytes infiltration
(black arrow) and synovitis (yellow arrow); d AC control +MM (250 mg/kg b.w.) showed the leukocytes infiltration (black arrow); e AC control +MM
(500 mg/kg b.w.) confirmed the normal architecture with less deformity of bone and cartilage; f AC control + Indo (10 mg/kg b.w.): treatment rats
demonstrated the recovered histopathological profile towards normal architecture with less deformity of bone and cartilage
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rats, due to elevated d level, it also started the accumula-
tion of neutrophils in the inflamed area. CFA-induced
arthritic rats that received MM significantly (P < 0.001)
declined the levels of MDA. GSH and SOD are the first
line antioxidants against scavenging the free radicals. SOD
coverts the superoxide radical to H2O2 and is widely used
to protect the cell damage during the toxic effects of O2
anion. First line antioxidants catalytically scavenge the
hydrogen peroxide (H2O2) and superoxide (O2-) mole-
cules. Endogenous antioxidant GPx reduced the H2O2 in
the presence of GSH to form oxidized glutathione and
water [49]. CFA-induced arthritic rats that received MM
had significantly (P < 0.001) modulated the level of an
antioxidant enzyme as compared to AC rats.
Many researchers have shown that the proinflammatory
mediators play a crucial role in the pathogenesis of arth-
ritis [50]. TNF-α (pleiotropic inflammatory cytokines)
plays a crucial role in pathogenesis of acute and chronic
inflammation, associated with the neutrophils and lym-
phocytes in endothelial cells via inflamed tissue. TNF-α,
present in sera and synovial fluid of arthritic patients is a
laboratory and clinical marker for estimation/confirmation
of RA disease [51–53]. It also promotes the generation of
macrophage chemotactic protein-1 (MCP-1), IL-6 and IL-
1β, which are involved in increasing the inflammatory
reaction. Macrophages release the proinflammatory IL-1β,
which enhances the inflammatory reaction. Both inflam-
matory cytokines (IL-1β and TNF-α) activated through
the osteoclasts and nuclear factor are responsible for re-
absorption and obliteration of bones. The generation of
proinflammatory cytokines such as IL-6 starts through the
T-cells, fibroblasts and monocytes, which initiate the in-
duction of osteoclast discrimination and stimulates the
MCP-1. All these proinflammatory cytokines are also
involved in enhancing the clinical sign of arthritis and
expansion of arthritic symptoms as well as body weight
loss and joint swelling [25, 27]. In the current study, we
observed a considerable enhancement of serum TNF-α,
IL-1β and IL-6 concentrations in AC group as compared
to NC group. Treatment with MM decreased the serum
levels of IL-1β, TNF-α and IL-6 without disturbing other
inflammatory mediators.
Conclusion
In conclusion, Melastoma malabathricum Linn was
effective in attenuating the CFA-induced arthritis rats in a
dose-dependently manner, and therefore it could be inves-
tigated as a probable treatment for chronic arthritis condi-
tions in humans. The results obtained from the current
study confirm the use of MM extract in traditional Indian
medicine for the management of painful inflammatory
and arthritic conditions. Additional work is going on to
isolate, characterize and identified the structure of phy-
toconstituents responsible for the antiarthritic activity.
Highlights
Melastoma malabathricum Linn reduced CFA induced
activation of the proinflammatory cytokines.
Melastoma malabathricum Linn reduced the CFA
induced activation of COX-2.
Melastoma malabathricum Linn significantly suppressed
the paw edema.
Melastoma malabathricum Linn modulation the CFA
induced antioxidant parameters.
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